Frontiers in Neurology (Mar 2022)
Interictal EEG and ECG for SUDEP Risk Assessment: A Retrospective Multicenter Cohort Study
- Zhe Sage Chen,
- Zhe Sage Chen,
- Aaron Hsieh,
- Guanghao Sun,
- Gregory K. Bergey,
- Samuel F. Berkovic,
- Samuel F. Berkovic,
- Piero Perucca,
- Piero Perucca,
- Piero Perucca,
- Piero Perucca,
- Piero Perucca,
- Wendyl D'Souza,
- Christopher J. Elder,
- Pue Farooque,
- Emily L. Johnson,
- Sarah Barnard,
- Sarah Barnard,
- Sarah Barnard,
- Russell Nightscales,
- Russell Nightscales,
- Russell Nightscales,
- Russell Nightscales,
- Patrick Kwan,
- Patrick Kwan,
- Patrick Kwan,
- Patrick Kwan,
- Brian Moseley,
- Terence J. O'Brien,
- Terence J. O'Brien,
- Terence J. O'Brien,
- Terence J. O'Brien,
- Shobi Sivathamboo,
- Shobi Sivathamboo,
- Shobi Sivathamboo,
- Shobi Sivathamboo,
- Juliana Laze,
- Daniel Friedman,
- Daniel Friedman,
- Orrin Devinsky,
- Orrin Devinsky,
- Orrin Devinsky,
- The MS-BioS Study Group
Affiliations
- Zhe Sage Chen
- Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, United States
- Zhe Sage Chen
- Neuroscience Institute, New York University Grossman School of Medicine, New York, NY, United States
- Aaron Hsieh
- Tandon School of Engineering, New York University, New York, NY, United States
- Guanghao Sun
- Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, United States
- Gregory K. Bergey
- Johns Hopkins University School of Medicine, Baltimore, MD, United States
- Samuel F. Berkovic
- Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia
- Samuel F. Berkovic
- Comprehensive Epilepsy Program, Department of Neurology, Austin Health, Heidelberg, VIC, Australia
- Piero Perucca
- Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia
- Piero Perucca
- Comprehensive Epilepsy Program, Department of Neurology, Austin Health, Heidelberg, VIC, Australia
- Piero Perucca
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia
- Piero Perucca
- Department of Neurology, Alfred Health, Melbourne, VIC, Australia
- Piero Perucca
- Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia
- Wendyl D'Souza
- 0Department of Medicine, St. Vincent's Hospital, The University of Melbourne, Fitzroy, VIC, Australia
- Christopher J. Elder
- 1Division of Epilepsy and Sleep, Columbia University, New York, NY, United States
- Pue Farooque
- 2Yale University School of Medicine, New Haven, CT, United States
- Emily L. Johnson
- Johns Hopkins University School of Medicine, Baltimore, MD, United States
- Sarah Barnard
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia
- Sarah Barnard
- Department of Neurology, Alfred Health, Melbourne, VIC, Australia
- Sarah Barnard
- 3Department of Neurology, New York University Grossman School of Medicine, New York, NY, United States
- Russell Nightscales
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia
- Russell Nightscales
- Department of Neurology, Alfred Health, Melbourne, VIC, Australia
- Russell Nightscales
- Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia
- Russell Nightscales
- 4Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia
- Patrick Kwan
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia
- Patrick Kwan
- Department of Neurology, Alfred Health, Melbourne, VIC, Australia
- Patrick Kwan
- Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia
- Patrick Kwan
- 4Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia
- Brian Moseley
- 5Clinical Development Neurocrine Biosciences Inc., San Diego, CA, United States
- Terence J. O'Brien
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia
- Terence J. O'Brien
- Department of Neurology, Alfred Health, Melbourne, VIC, Australia
- Terence J. O'Brien
- Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia
- Terence J. O'Brien
- 4Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia
- Shobi Sivathamboo
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia
- Shobi Sivathamboo
- Department of Neurology, Alfred Health, Melbourne, VIC, Australia
- Shobi Sivathamboo
- Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia
- Shobi Sivathamboo
- 4Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia
- Juliana Laze
- 6Comprehensive Epilepsy Center, New York University Langone Health, New York, NY, United States
- Daniel Friedman
- 3Department of Neurology, New York University Grossman School of Medicine, New York, NY, United States
- Daniel Friedman
- 6Comprehensive Epilepsy Center, New York University Langone Health, New York, NY, United States
- Orrin Devinsky
- Neuroscience Institute, New York University Grossman School of Medicine, New York, NY, United States
- Orrin Devinsky
- 3Department of Neurology, New York University Grossman School of Medicine, New York, NY, United States
- Orrin Devinsky
- 6Comprehensive Epilepsy Center, New York University Langone Health, New York, NY, United States
- The MS-BioS Study Group
- DOI
- https://doi.org/10.3389/fneur.2022.858333
- Journal volume & issue
-
Vol. 13
Abstract
ObjectiveSudden unexpected death in epilepsy (SUDEP) is the leading cause of epilepsy-related mortality. Although lots of effort has been made in identifying clinical risk factors for SUDEP in the literature, there are few validated methods to predict individual SUDEP risk. Prolonged postictal EEG suppression (PGES) is a potential SUDEP biomarker, but its occurrence is infrequent and requires epilepsy monitoring unit admission. We use machine learning methods to examine SUDEP risk using interictal EEG and ECG recordings from SUDEP cases and matched living epilepsy controls.MethodsThis multicenter, retrospective, cohort study examined interictal EEG and ECG recordings from 30 SUDEP cases and 58 age-matched living epilepsy patient controls. We trained machine learning models with interictal EEG and ECG features to predict the retrospective SUDEP risk for each patient. We assessed cross-validated classification accuracy and the area under the receiver operating characteristic (AUC) curve.ResultsThe logistic regression (LR) classifier produced the overall best performance, outperforming the support vector machine (SVM), random forest (RF), and convolutional neural network (CNN). Among the 30 patients with SUDEP [14 females; mean age (SD), 31 (8.47) years] and 58 living epilepsy controls [26 females (43%); mean age (SD) 31 (8.5) years], the LR model achieved the median AUC of 0.77 [interquartile range (IQR), 0.73–0.80] in five-fold cross-validation using interictal alpha and low gamma power ratio of the EEG and heart rate variability (HRV) features extracted from the ECG. The LR model achieved the mean AUC of 0.79 in leave-one-center-out prediction.ConclusionsOur results support that machine learning-driven models may quantify SUDEP risk for epilepsy patients, future refinements in our model may help predict individualized SUDEP risk and help clinicians correlate predictive scores with the clinical data. Low-cost and noninvasive interictal biomarkers of SUDEP risk may help clinicians to identify high-risk patients and initiate preventive strategies.
Keywords